An open-label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to Wegovy.

In their new book, Learning Together, Elham Kazemi and colleagues suggest school leaders work with teachers to analyze ...

Speaking at the Clinical Trials in Oncology conference in Munich, GlobalData’s Ophelia Chan broke down how many real world data saves trials.